Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Duesseldorf – page 70

2 009 clinical trials in Duesseldorf, Germany across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Duesseldorf at a glance
2 009
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

2 009 trials in Duesseldorf

Open in trial search

Ischaemic stroke

Not yet recruiting

Enhanced dual antiplatelet therapy with clopidogrel and acetylsalicylic acid for secondary prevention in patients with mild ischemic stroke

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Technische Universitat Dresden

Endometrial cancer

Not yet recruiting

Study of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:GSK5733584
  • Sponsor:Glaxosmithkline Research & Development Limited

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Deupirfenidone
  • Sponsor:Celea Therapeutics Inc.

Choroid melanoma

Not yet recruiting

Long‑Term Follow‑Up Study of Belzupacap Sarotalocan in Patients with Early Choroidal Melanoma

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Belzupacap Sarotalocan
  • Sponsor:Aura Biosciences Inc.

Hodgkin's disease

Not yet recruiting

Phase II Study of Brentuximab Vedotin with Drug Combination in HIV‑Positive Patients with Advanced‑Stage Classic Hodgkin Lymphoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Brentuximab Vedotin
  • Sponsor:University Of Cologne

Varicella+5

Not yet recruiting

Immune response and safety of investigational MMRV vaccine (GSKVX000000025896) drug combination compared with standard MMRV vaccine in healthy children 15 months to 6 years

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · Healthy volunteers
  • Substances:GSKVX000000025896
  • Sponsor:GlaxoSmithKline Biologicals

Optic ischaemic neuropathy

Not yet recruiting

Efficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120
  • Sponsor:AstraZeneca AB

Neoplasm

Not yet recruiting

Study of sacituzumab govitecan versus investigator’s choice drug combination in patients with cancer of unknown primary after platinum‑based chemotherapy failure

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Neuroendocrine carcinoma

Not yet recruiting

Phase II Study of BI 764532 Added to Platinum Chemotherapy in Adults with Advanced Large‑Cell Neuroendocrine Lung Cancer

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Obrixtamig
  • Sponsor:Technische Universitat Dresden

Glioblastoma multiforme

Not yet recruiting

Study of autologous mature dendritic cell vaccine plus atezolizumab in patients with recurrent glioblastoma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Heinrich-Heine-Universitaet Duesseldorf

Stargardt's disease

Not yet recruiting

Phase 3 Study of Gildeuretinol Acetate (ALK‑001) to Assess Safety and Efficacy in Slowing Progression of Stargardt Disease in Adults

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Gildeuretinol acetate
  • Sponsor:Alkeus Pharmaceuticals Inc.

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Duesseldorf

What the registry says about research in the country

01 Oncology and Hematologic Malignancies

In Düsseldorf, a large share of trials focuses on cancer research and blood cancers, with studies in breast cancer, colorectal cancer, prostate cancer, multiple myeloma, and leukemia. These trials are mainly testing new treatment combinations, improving post-surgery care, and exploring ways to delay or prevent recurrence.

  • Breast cancer and triple-negative breast cancer research
  • Colorectal cancer, prostate cancer, and other solid tumors
  • Multiple myeloma, lymphoma, AML, and MDS
  • Testing new therapy strategies and improving treatment outcomes

This field is especially active across the city’s research sites, reflecting a strong interest in both common and hard-to-treat malignancies.

02 Dermatology and Hair Disorders

Another important area is skin and connective tissue disease research, including studies on psoriasis, actinic keratosis, androgenetic alopecia, and facial line treatments. These trials are mainly aimed at evaluating new topical or injectable therapies and improving visible symptom control.

  • Moderate to severe plaque psoriasis
  • Actinic keratosis of the face or scalp
  • Androgenetic alopecia in men and women
  • Facial line and cosmetic treatment studies

Several of these studies are designed to compare active treatment with control care and help refine everyday dermatologic treatment options.

03 Digestive and Liver Diseases

Trials in digestive system diseases and virus diseases include research on chronic hepatitis D, metabolic dysfunction-associated steatotic liver disease, and advanced cancers involving the pancreas, colon, and bile ducts. The main goal is to improve treatment effectiveness and support better disease control in difficult liver and gastrointestinal conditions.

  • Chronic hepatitis D infection
  • Metabolic dysfunction-associated steatotic liver disease
  • Pancreatic, colon, and cholangiocarcinoma studies
  • Testing new therapies and surgery-related strategies

These studies highlight a strong focus on therapies for chronic liver illness and advanced abdominal cancers.

04 Neurology and Multiple Sclerosis

Research in nervous system diseases includes trials for multiple sclerosis and other neurological conditions, with an emphasis on long-term safety and treatment benefit. In Düsseldorf, these studies are helping assess whether newer immune-based approaches can better support patients over time.

  • Relapsing multiple sclerosis
  • Progressive multiple sclerosis
  • Broader nervous system disease research
  • Evaluating treatment safety and durability

This area reflects ongoing interest in therapies that may offer steadier disease control with acceptable tolerability.

05 Pediatric and Adolescent Conditions

Pediatric trials cover serious conditions such as high-risk neuroblastoma, acute lymphoblastic leukemia, and respiratory distress in preterm infants. These studies aim to improve survival, reduce complications, and support better long-term outcomes in children and young people.

  • High-risk neuroblastoma
  • Ph+ and ABL-class B-cell acute lymphoblastic leukemia
  • Respiratory distress syndrome in preterm infants
  • Testing more effective treatment and prevention approaches

These trials bring together cancer care and neonatal research, showing a wide pediatric research footprint in the city.

06 Hematology and Bone Marrow Disorders

Several studies address hemic and lymphatic diseases, especially myelodysplastic syndromes, anemia, and refractory hematologic malignancies. The purpose is to find better ways to restore blood counts, improve transfusion independence, and treat patients whose disease has returned or no longer responds to standard therapy.

  • Lower-risk myelodysplastic syndromes
  • Anemia linked to marrow disorders
  • Relapsed or refractory mantle cell lymphoma
  • Evaluating new blood cancer treatments

This research area is particularly important for patients with limited treatment options and persistent blood-related symptoms.

07 Endocrine and Metabolic Research

Düsseldorf also hosts trials in hormonal diseases and nutritional and metabolic diseases, including work on hair loss linked to hormonal imbalance and liver-related metabolic disorders. These studies are designed to test treatment effectiveness and improve symptom management in conditions that often affect quality of life.

  • Hormone-related hair loss
  • Metabolic liver disease
  • Treatment studies in endocrine and metabolic care
  • Assessing benefit and safety of newer therapies

These trials connect chronic metabolic care with visible, patient-centered outcomes.

08 Immunology and Infectious Disease-Related Research

The city’s trial portfolio includes immune system disease research and studies linked to virus diseases, especially where immune pathways affect chronic illness or cancer care. Researchers are exploring new treatment options that may improve control of persistent viral infection and immune-driven disease.

  • Chronic hepatitis D
  • Immune-related treatment strategies
  • Conditions involving chronic inflammation and infection
  • Evaluating newer immune-targeted therapies

This work shows how immunology and virology often overlap in modern clinical research.

09 Diagnostic Imaging and Research Tools

A smaller but important part of the research landscape involves diagnostic techniques and equipment, including studies that assess how well advanced imaging can identify disease and guide care. These trials are focused on improving diagnosis and helping clinicians distinguish between disease subtypes more accurately.

  • Prostate cancer imaging and diagnosis
  • Evaluating PET-based diagnostic performance
  • Improving disease classification
  • Supporting earlier and more precise diagnosis

In Düsseldorf, diagnostic research complements the treatment studies by strengthening the tools used to identify and monitor disease.

10 Respiratory and Early-Life Health

Trials in respiratory tract diseases include research aimed at improving outcomes for preterm infants with breathing problems early in life. The focus is on prevention and better long-term lung function, with the goal of reducing complications that can affect childhood development.

  • Respiratory distress syndrome in premature babies
  • Early intervention and prevention strategies
  • Long-term lung health
  • Supporting better outcomes in neonatal care

This area links specialized newborn care with research designed to improve later respiratory health.

11 Broad Experimental and Translational Studies

Some trials in Düsseldorf span advanced solid tumors and other difficult-to-treat conditions, reflecting a broad translational research effort. These studies are often designed to test whether new therapies can produce meaningful disease control in patients with limited standard options.

  • Advanced solid tumors
  • Mixed oncology populations
  • Early evaluation of promising therapies
  • Exploring anti-tumor activity and safety

This part of the research landscape supports the development of new approaches across multiple cancer types.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.